The Valley Desk

NCT00992732 · Interventional trial

Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders

Overall registry status Terminated

Phase 2

Conditions Lymphoid Malignancies, Lymphoproliferative Disorders

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov